Check Before You Invest : Astal Laboratories Ltd

Snapshot

Q.1 Which industry/sub-sector does Astal Laboratories Ltd belong to?

Astal Laboratories Ltd belongs to the Healthcare sector, operating specifically within the Pharmaceuticals & Drugs segment.

Q.2 Is Astal Laboratories Ltd a good quality company?

Astal Laboratories Ltd is a weak quality company, based on a inconsistent 3-year financial track record.

Q.3 Is Astal Laboratories Ltd undervalued or overvalued?

Astal Laboratories Ltd appears Overvalued, as its key valuation ratios are above with their past averages.

Q.4 Is Astal Laboratories Ltd a good buy now?

Astal Laboratories Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Return on capital employed (ROCE) of Astal Laboratories Ltd?

Astal Laboratories Ltd Return on capital employed is 34.78% for FY-2025, which is above its 3-year historical median of 7.62%. The current ROCE is above its estimated weighted average cost of capital (WACC) of 14%, indicating value creation.

Q.2 Return on Asset of Astal Laboratories Ltd?

Astal Laboratories Ltd Return on Asset is 17.86%, which is above its 3-year historical median of 3.37%, indicating improved asset utilization efficiency.

Q.3 Return on Equity (ROE) of Astal Laboratories Ltd?

Astal Laboratories Ltd Return on equity is 32.12% for FY-2025, which is above its 3-year historical median of 5.51%, indicating the business is making better use of its shareholders capital.

Q.4 Cash conversion cycle of Astal Laboratories Ltd?

Astal Laboratories Ltd Cash conversion cycle is 87 days, above its 3-year historical median of 31 days, indicating deteriorated working capital management. However, you need to compare this with its peers in the industry.

	Current Level	3-year Historic Median
Asset Turnover	1.29	1.02
ROE	32.12	5.51
ROCE	34.78	7.62
Cash Conversion Cycle	87 days	31 days

Q.5 Gross Profit margin of Astal Laboratories Ltd?

Astal Laboratories Ltd Gross profit margin which is the profit after deduction of direct costs, is 19% for FY-2025, which is above its 3-year median of 4.7%, indicating increasing margins.

Q.6 Operating Profit Margin of Astal Laboratories Ltd?

Astal Laboratories Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 19.89% for FY-2025, which is above its 3-year median of 4.71% indicating increasing margins.

Q.7 Net Profit Margin of Astal Laboratories Ltd?

Astal Laboratories Ltd Net Profit Margin is 13.9% for FY-2025, is above with its 3-year median of 3.32%, indicating increasing margins.

	Current Level	3-year Historic Median
Gross Profit Margin	19	4.7
Operating Profit Margin	19.89	4.71
Net Profit Margin	13.9	3.32

Q.8 Debt to Equity ratio of Astal Laboratories Ltd?

Astal Laboratories Ltd Debt-to-Equity ratio is 0.41, which is above with the industry average of 0.25, indicating higher debt levels in the industry.

Q.9 Debt to cash flow from operations of Astal Laboratories Ltd?

Astal Laboratories Ltd Debt to cash flow from operations is -1.06, which is at a unhealthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of Astal Laboratories Ltd?

Promoters hold 4.70% of the Astal Laboratories Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of Astal Laboratories Ltd vs industry peers?

Astal Laboratories Ltd revenue CAGR is 0.00%, compared to the industry median CAGR of 8.24%, indicating slower growth and losing its market share.

Profit Metrics

	Current Level	3-year Industry Median
Revenue Growth	-	8.2
Gross Profit Growth	1,100	11.2
Operating Profit Growth	1,200	9.8
Net Profit Growth	800	NAN

Operating Efficiency

	Current Level	3-year Industry Median
Asset Turnover	1.29	0.78
ROE	32.12	9.5
ROCE	34.78	11.4
Cash Conversion Cycle (days)	87.46	83

Valuation & price assessment

Q.1 Stock return of Astal Laboratories Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 11.1% based on the current price.

Q.2 What return has the stock given over the last decade?

	9Y	5Y	3Y	1Y
Share Price CAGR	11.1%	48.5%	26.7%	-23.1%

Q.3 Valuation ratios of Astal Laboratories Ltd vs historical?

The current P/E is lower that its historical median.

Q.4 How do the current valuation ratios compare with 3-year historical median and industry numbers?

Valuation Ratios	Current	3-year Historic Median	3-year Industry Median
Price to Earnings	27.25	34.09	33.44
Price to Book	3.31	2.46	3.09
Price to Sales	1.92	2.24	3.40
EV to EBITDA	18.37	23.78	16.10

Check more companies

5. Wockhardt

9. Pfizer

10. Neuland Laboratories

Check trending companies

1. Mangalore Refinery And Petrochemicals Ltd.

2. BLS International Services Ltd.

3. Clean Science And Technology Ltd.

4. Bikaji Foods International Ltd.

5. Kaynes Technology India Ltd.